IRIS
ROSSI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.695
EU - Europa 1.211
NA - Nord America 868
SA - Sud America 261
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.094
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 878
US - Stati Uniti d'America 824
RU - Federazione Russa 596
CN - Cina 447
IT - Italia 309
BR - Brasile 198
HK - Hong Kong 131
VN - Vietnam 106
NL - Olanda 81
DE - Germania 79
KR - Corea 42
FI - Finlandia 28
CI - Costa d'Avorio 26
AR - Argentina 24
CA - Canada 24
IN - India 24
GB - Regno Unito 19
FR - Francia 17
MX - Messico 16
AT - Austria 15
ZA - Sudafrica 14
BD - Bangladesh 13
IE - Irlanda 12
ID - Indonesia 10
LT - Lituania 10
BG - Bulgaria 9
UY - Uruguay 9
EC - Ecuador 8
SE - Svezia 7
ES - Italia 6
PY - Paraguay 6
TR - Turchia 6
UA - Ucraina 6
IL - Israele 5
PK - Pakistan 5
PL - Polonia 5
CL - Cile 4
CO - Colombia 4
EG - Egitto 4
IQ - Iraq 4
JP - Giappone 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
MA - Marocco 3
MY - Malesia 3
TN - Tunisia 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
JO - Giordania 2
LV - Lettonia 2
AZ - Azerbaigian 1
BE - Belgio 1
BJ - Benin 1
CH - Svizzera 1
CU - Cuba 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NE - Niger 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 4.094
Salva come PNG Salva come JPEG
Città #
Singapore 429
Hefei 229
Hong Kong 131
Moscow 129
Naples 115
Ashburn 93
Beijing 86
Santa Clara 80
Chandler 74
Amsterdam 56
Ho Chi Minh City 49
Seoul 42
Los Angeles 33
Millbury 26
Hanoi 22
Redondo Beach 21
Buffalo 17
Helsinki 16
Lawrence 16
Munich 16
New York 16
São Paulo 16
Dallas 15
Nuremberg 13
Boston 12
Rome 12
Falkenstein 11
Napoli 11
The Dalles 11
Chicago 10
Frankfurt am Main 10
Mexico City 10
Milan 10
Seattle 10
Des Moines 9
Ottawa 8
Rio de Janeiro 8
Sofia 8
Columbus 7
Groningen 7
Johannesburg 7
Montevideo 7
Montreal 7
Wilmington 7
Brooklyn 6
Denver 6
Jacksonville 6
Kronberg 6
Marigliano 6
Torre Annunziata 6
Afragola 5
Belo Horizonte 5
Boardman 5
Bologna 5
London 5
Princeton 5
Quito 5
Recife 5
Turku 5
Warsaw 5
Washington 5
Caserta 4
Chennai 4
Council Bluffs 4
Kochi 4
Orta di Atella 4
Piracicaba 4
Portici 4
Porto Alegre 4
Redwood City 4
Stockholm 4
Tokyo 4
Vienna 4
Vilnius 4
Andover 3
Ann Arbor 3
Bengaluru 3
Biên Hòa 3
Brasília 3
Buenos Aires 3
Changsha 3
Charlotte 3
Curitiba 3
Da Nang 3
Houston 3
Jakarta 3
Lappeenranta 3
Manchester 3
Marcianise 3
Nanjing 3
Orem 3
Pune 3
Quartu Sant'Elena 3
San Francisco 3
Santo André 3
Suzano 3
São Gonçalo 3
Toronto 3
Tunis 3
Volla 3
Totale 2.143
Salva come PNG Salva come JPEG
Nome #
A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net 157
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 133
An Overview of Hypoglycemia in Children Including a Comprehensive Practical Diagnostic Flowchart for Clinical Use 130
Metabolic stroke-like events in a girl with pyruvate dehydrogenase complex deficiency caused by a novel de novo mutation in PDHA1 123
Combined biochemical profiling and DNA sequencing in the expanded newborn screening for inherited metabolic diseases: the experience in an Italian reference center 119
Contribution of Genetic Test to Early Diagnosis of Methylenetetrahydrofolate Reductase (MTHFR) Deficiency: The Experience of a Reference Center in Southern Italy 118
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 114
Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria? 111
Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment 104
Plasma acylcarnitines and urine organic acids profiles provide evidence for possible mitochondrial dysfunction in glycogen storage disease type Ia 104
Imbalanced cortisol concentrations in glycogen storage disease type I: Evidence for a possible link between endocrine regulation and metabolic derangement 103
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report 101
Clinical and biochemical footprints of inherited metabolic diseases. XIII. Respiratory manifestations 96
Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia 93
Involvement of endocrine system in a patient affected by glycogen storage disease 1b: speculation on the role of autoimmunity 92
An asymptomatic father diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency following his son newborn screening test 91
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire 91
Bone metabolism in patients with type 1 neurofibromatosis: key role of sun exposure and physical activity 90
Severe hypercalcemia associated with hypophosphatemia in very premature infants: a case report 88
Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations. 87
Dynamic Methods for Childhood Hypoglycemia Phenotyping: A Narrative Review 87
Liver-Directed Adeno-Associated Virus–Mediated Gene Therapy for Mucopolysaccharidosis Type VI 87
Long-term monitoring for short/branched-chain acyl-CoA dehydrogenase deficiency: A single-center 4-year experience and open issues 86
Primrose syndrome: Characterization of the phenotype in 42 patients 86
Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy 85
Peritoneal tuberculosis mimicking carcinomatous ascites in a child living in a low prevalence country: a case report 84
Mapping challenges in the accessibility of treatment products for urea cycle disorders: A survey of European healthcare professionals 83
Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature 81
Bronchial isomerism in a Kabuki syndrome patient with a novel mutation in MLL2 gene 81
Glycogen storage disease type Ia: Current management options, burden and unmet needs 81
Biomarkers for gene therapy clinical trials of lysosomal storage disorders 78
A specific serum lipid signature characterises patients with glycogen storage disease type Ia 77
Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care 75
Cervical spondylolisthesis in mucopolysaccharidosis type II 74
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 74
Long-term use of carglumic acid in methylmalonic aciduria, propionic aciduria and isovaleric aciduria in Italy: a qualitative survey 71
Early diagnosis and treatment in a child with foodborne botulism 70
Gene therapies for mucopolysaccharidoses 65
A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: towards glycemic targets 64
Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b 56
Towards values-based healthcare for inherited metabolic disorders: An overview of current practices for persons with liver glycogen storage disease and fatty acid oxidation disorders 54
Continuous glucose monitoring metrics in people with liver glycogen storage disease and idiopathic ketotic hypoglycemia: A single-center, retrospective, observational study 50
Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop 50
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose 46
State of the Art and Consensus Statements by Healthcare Providers, Patients, and Caregivers on Continuous Glucose Monitoring in Liver Glycogen Storage Diseases 46
Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1 41
Commentary on ‘Lentivirus-mediated gene therapy for Fabry disease: 5-year end-of-study results from the Canadian FACTS trial’ 40
State of the art management practices for liver glycogen storage disorders: Results from an international survey among metabolic centres 38
Liver-directed gene-based therapies for inborn errors of metabolism 37
Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia 28
Variants in GSTZ1 Gene Underlying Maleylacetoacetate Isomerase Deficiency: Characterization of Two New Individuals and Literature Review 22
Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines 21
Totale 4.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 3 1 0 4 0 6 4
2021/2022122 1 0 0 0 1 1 1 2 20 9 27 60
2022/2023272 25 18 9 19 24 18 4 28 34 53 24 16
2023/2024263 24 32 28 15 20 13 3 56 0 10 40 22
2024/20251.514 64 58 16 14 26 144 141 149 77 184 514 127
2025/20261.871 312 330 337 325 500 67 0 0 0 0 0 0
Totale 4.163